LEXARIA BIOSCIENCE CORP. (OTCMKTS:LXRP) Files An 8-K Regulation FD DisclosureItem 7.01 Regulation FD Disclosure
On March 13, 2018 Lexaria Bioscience Corp. (“Lexaria”) issued a news release announcing it has completed its first study evaluating DehydraTECHTM used in a topical cream formulation. The news release is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.
On March 14, 2018 Lexaria issued news release announcing that it has commenced its first nicotine in vivo (animal) absorption and tolerability study. The news release is filed as exhibit 99.2 to this current report and is hereby incorporated by reference.
Item 9.01 Financial Statements and Exhibits
Lexaria Bioscience Corp. ExhibitEX-99.1 2 exhibit99-1.htm EXHIBIT 99.1 Lexaria Bioscience Corp. – Exhibit 99.1 – Filed by newsfilecorp.com Exhibit 99.1 Lexaria Bioscience Corp Completes Successful Skin Absorption Study Kelowna,…To view the full exhibit click here
About LEXARIA BIOSCIENCE CORP. (OTCMKTS:LXRP)
Lexaria Bioscience Corp., formerly Lexaria Corp., is a food sciences company. The Company is focused on the delivery of cannabinoid compounds procured from legal, agricultural hemp, through gourmet foods based upon its infusion technologies. Its food sciences activities include the development of its nutrient infusion technologies for the production of superfoods, and the production of food products under its two consumer product brands, ViPova and Lexaria Energy. Its technology is developed to aid absorption and bioavailability of various payload molecules, including cannabinoids, such as cannabidiol (CBD) and tetrahydrocannabinol (THC). Its range of flavors to the ViPova family, are available in 8 to 32 bag portions: Decaf English Breakfast, Earl Grey, Herbal Bengal Chai, Herbal Cherry Black Tea, Herbal Masala Chai, Low-Caf Organic Evening Green Tea and ViPova Light. It produces and sells edible consumer products infused with cannabidiol and available for sale in over 50 states.
